Health Care & Life Sciencehttps://www.jonesday.com/en/rss/practices/health-careHealth Care - Jones Dayen{279CCA71-20FA-4D5F-B7BD-E6B7FBF925C3}https://www.jonesday.com/en/insights/2026/04/a-tough-dose-100-tariffs-target-foreignmanufactured-brandname-pharmaceuticalsAlertA Tough Dose: 100% Tariffs Target Foreign-Manufactured Brand-Name PharmaceuticalsWed, 08 Apr 2026 12:43:00 -0500{5B5CD28A-8562-46B6-9F27-57009B4163E2}https://www.jonesday.com/en/news/2026/04/jones-day-international-legal-fellowship-commences-for-2026Firm NewsJones Day International Legal Fellowship commences for 2026Wed, 01 Apr 2026 12:12:02 -0500{E2787E9A-C42E-4A18-BFA9-41BBCE3746D1}https://www.jonesday.com/en/insights/2026/03/access-granted-outcome-and-valuebased-cms-model-for-digital-health-managementAlertACCESS Granted: Outcome and Value-Based CMS Model for Digital Health Management Thu, 26 Mar 2026 07:50:00 -0500{28FD76CC-26CC-4CFE-8C60-728197D9ECD0}https://www.jonesday.com/en/insights/2026/03/unintended-consequences-gao-report-questions-impact-of-exercising-marchin-rights-for-drug-pricingCommentaryUnintended Consequences: GAO Report Questions Impact of Exercising March-In Rights for Drug PricingFri, 20 Mar 2026 04:16:00 -0500{A2657A84-6824-4F39-B61B-A48AB0AD7DEC}https://www.jonesday.com/en/news/2026/03/crains-detroit-selects-ann-hollenbeck-for-inclusion-in-its-notable-women-in-law-listAwards & RankingsCrain's Detroit selects Ann Hollenbeck for inclusion in its "Notable Women in Law" listTue, 17 Mar 2026 04:54:41 -0500{74C7AD18-AF4B-485A-BFEC-80679A1DA975}https://www.jonesday.com/en/insights/2026/03/jones-day-talks-the-cnpv-pilot-program--fdas-highspeed-lane-for-drug-approvalPodcastJONES DAY TALKS®: The CNPV Pilot Program – FDA’s High-Speed Lane for Drug ApprovalTue, 03 Mar 2026 03:55:00 -0600{D7365ABD-4CF3-4310-B7F1-B5C1A459E8E4}https://www.jonesday.com/en/insights/2026/03/the-uks-mhra-opens-public-consultation-on-indefinite-ce-mark-recognition-of-medical-devices-and-ivdsAlertThe UK's MHRA Opens Public Consultation on Indefinite CE Mark Recognition of Medical Devices and IVDsMon, 02 Mar 2026 08:21:00 -0600{8055DD98-3FE0-45DC-B943-7470525E51C0}https://www.jonesday.com/en/insights/2026/02/caught-in-the-crossfire-bigmedicine-breakup-bill-imperils-longestablished-integrated-health-systemsAlertCaught in the Crossfire: Big-Medicine Breakup Bill Imperils Long-Established Integrated Health SystemsFri, 27 Feb 2026 09:53:00 -0600{05DC101C-CD73-4FE5-B093-67CA82063A6C}https://www.jonesday.com/en/insights/2026/02/2025-securities-litigation-year-in-reviewWhite PaperYear in Review2025 Securities Litigation Year in ReviewThu, 26 Feb 2026 12:22:00 -0600{4EFAE9EF-EC83-4314-9A23-CB76E10B43D3}https://www.jonesday.com/en/insights/2026/02/take-the-lead-cms-launches-tenyear-aco-model-to-increase-provider-participationAlertTake the LEAD: CMS Launches 10-Year ACO Model to Increase Provider Participation Tue, 24 Feb 2026 04:00:00 -0600{7D1BFC15-2D37-4236-B065-C15BEF813D0B}https://www.jonesday.com/en/insights/2026/02/federal-court-rules-that-a-defendants-communications-with-generative-ai-are-not-privilegedAlertFederal Court Rules that a Defendant's Communications With Generative AI are Not PrivilegedFri, 20 Feb 2026 10:42:00 -0600{39D7675D-5E06-4B36-A236-BCB283F2D47B}https://www.jonesday.com/en/insights/2026/02/eu-geopolitical-risk-update--key-policy--regulatory-developments-no-125NewslettersEU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 125Wed, 18 Feb 2026 08:20:00 -0600{2110FD1E-9ECC-49BD-803B-8FF4F95A2652}https://www.jonesday.com/en/insights/2026/02/hhs-signals-policy-direction-to-accelerate-adoption-of-ai-in-clinical-careAlertHHS Signals Policy Direction to Accelerate Adoption of AI in Clinical CareMon, 09 Feb 2026 08:34:00 -0600{021BAA68-F220-4940-850B-14E2DD5C341D}https://www.jonesday.com/en/insights/2026/02/newsletter-vital-signs-digital-health-law-update--winter-2026NewslettersVital Signs: Digital Health Law Update | Winter 2026Thu, 05 Feb 2026 09:05:00 -0600{FA231A8F-6E77-4100-82BC-222B961F4123}https://www.jonesday.com/en/insights/2026/02/cmmi-seeks-lifestyle-interventions-that-improve-health-outcomes-under-new-modelAlertCMMI Seeks Lifestyle Interventions That Improve Health Outcomes Under New ModelMon, 02 Feb 2026 04:07:44 -0600{A4C1ED6E-6DC4-4971-8723-29238FE6F031}https://www.jonesday.com/en/insights/2026/01/ema-and-fda-align-on-good-ai-practice-in-drug-developmentAlertEMA and FDA Align on Good AI Practice in Drug DevelopmentWed, 28 Jan 2026 05:40:43 -0600{E110BF1E-FB2B-415A-9278-A36DC067F404}https://www.jonesday.com/en/insights/2026/01/false-claims-act-recoveries-reach-record-68-billion-in-fiscal-year-2025AlertFalse Claims Act Recoveries Reach Record $6.8 Billion in Fiscal Year 2025Tue, 27 Jan 2026 08:54:00 -0600{7C0A1B18-1AFD-4D88-B05C-28D1DE942FDD}https://www.jonesday.com/en/insights/2026/01/a-relaxing-2026-fda-updates-general-wellness-and-clinical-decision-support-software-guidanceAlertA Relaxing 2026? FDA Updates General Wellness and Clinical Decision Support Software GuidanceThu, 22 Jan 2026 00:00:00 -0600{19AFD869-E316-4073-8D6C-AD661F3647D2}https://www.jonesday.com/en/insights/2026/01/eu-geopolitical-risk-update--key-policy--regulatory-developments-no-124NewslettersEU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 124Fri, 09 Jan 2026 00:00:00 -0600{50ECC9F4-729F-4B39-A01E-5E18CE5E4033}https://www.jonesday.com/en/insights/2025/12/cms-proposes-mfn-drug-pricing-strategy-for-mandatory-globe-and-guard-modelsAlertCMS Proposes MFN Drug Pricing Strategy for Mandatory GLOBE and GUARD ModelsWed, 31 Dec 2025 00:00:00 -0600{A655B61A-0A94-4B08-8EA5-73E9CCE83641}https://www.jonesday.com/en/insights/2025/12/from-fragmented-to-framework-executive-order-advances-national-ai-consistencyAlertFrom Fragmented to Framework: Executive Order Advances National AI ConsistencyFri, 19 Dec 2025 00:00:00 -0600{1760A9ED-7CB1-4763-8036-F5958BE5C2BB}https://www.jonesday.com/en/insights/2025/12/fda-drives-digital-health-forwardAlertFDA Drives Digital Health Forward With Pilot Program for Chronic Condition DevicesThu, 18 Dec 2025 00:00:00 -0600{2FCD78F1-703A-412B-BD07-8B133030FD1A}https://www.jonesday.com/en/insights/2025/12/the-eu-pharma-package-is-a-done-deal-a-holiday-gift-or-notCommentaryThe EU Pharma Package Is a Done Deal: a Holiday Gift, or Not?Thu, 18 Dec 2025 00:00:00 -0600{E2C4E277-381A-4ADC-86A6-15B5D60CF24A}https://www.jonesday.com/en/news/2025/12/jones-day-will-be-in-san-francisco-during-the-44th-annual-jp-morgan-healthcare-conferenceJones Day will be in San Francisco during the 44th Annual J.P. Morgan Healthcare ConferenceWed, 17 Dec 2025 00:00:00 -0600{ECE06F87-3BBD-4959-89F8-1A25CDD49080}https://www.jonesday.com/en/insights/2025/12/innovative-insights-legal-updates-in-life-sciences-fourth-quarter-2025NewslettersInnovative Insights: Legal Updates in Life Sciences | Fourth Quarter 2025Thu, 11 Dec 2025 00:00:00 -0600{B4A9250E-1666-419F-A80E-13101E017F69}https://www.jonesday.com/en/insights/2025/12/balancing-possibilities-with-realitiescyber-and-privacy-legal-trends-in-life-sciencesNewslettersBalancing Possibilities with Realities—Cyber and Privacy Legal Trends in Life SciencesThu, 04 Dec 2025 00:00:00 -0600{C0C58793-4722-429D-8420-3DFA772E9FFF}https://www.jonesday.com/en/insights/2025/12/commissioners-national-priority-voucher-program-and-coverage-considerationsNewslettersCommissioner's National Priority Voucher Program and Coverage ConsiderationsThu, 04 Dec 2025 00:00:00 -0600{D9AF84B7-A5A7-4069-BD01-4BD8E79F3010}https://www.jonesday.com/en/insights/2025/12/fdas-support-for-onshoring-drug-manufacturing-and-increasing-oversight-of-foreign-facilitiesNewslettersFDA's Support for Onshoring Drug Manufacturing and Increasing Oversight of Foreign FacilitiesThu, 04 Dec 2025 00:00:00 -0600{4575EFC6-1E68-40AF-A578-3C1B24F4CA4E}https://www.jonesday.com/en/insights/2025/12/most-favored-nation-drug-pricing-and-manufacturer-agreementsNewslettersMost Favored Nation Drug Pricing and Manufacturer AgreementsThu, 04 Dec 2025 00:00:00 -0600{EF4E81FA-0946-48BE-AF75-14FAEF8F5C9C}https://www.jonesday.com/en/insights/2025/12/the-current-legal-landscape-of-the-340b-drug-pricing-programNewslettersThe Current Legal Landscape of the 340B Drug Pricing ProgramThu, 04 Dec 2025 00:00:00 -0600{4CABFCF8-DC8D-4170-B88A-A51D309B3A40}https://www.jonesday.com/en/insights/2025/12/trump-administration-updates-for-the-life-sciences-industry--q4-editionNewslettersTrump Administration Updates for the Life Sciences Industry Q4 Edition Thu, 04 Dec 2025 00:00:00 -0600{1E7D351D-7087-473D-9590-13E79DFF8F22}https://www.jonesday.com/en/insights/2025/12/fda-biosimilar-playbook-merging-biosimilarity-with-interchangeabilityCommentaryFDA's Biosimilar Playbook: Merging Biosimilarity with InterchangeabilityWed, 03 Dec 2025 00:00:00 -0600{F32C4D4E-237A-44EC-BB33-7E8EAE7C3E1B}https://www.jonesday.com/en/insights/2025/12/eu-geopolitical-risk-update--key-policy--regulatory-developments-no-123NewslettersEU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 123Mon, 01 Dec 2025 00:00:00 -0600{12E38887-5572-4CD0-B9B0-BE13008EB8C8}https://www.jonesday.com/en/insights/2025/11/japanese-government-considers-potential-improvements-to-patent-linkage-system-for-genericsCommentaryJapanese Government Considers Potential Improvements to Patent Linkage System for GenericsTue, 25 Nov 2025 00:00:00 -0600{F9A0A0D6-5A66-4FD5-86D0-F6CA22159620}https://www.jonesday.com/en/news/2025/11/jones-day-named-law-firm-of-the-year-in-appellate-practice-among-293-rankings-in-the-2026-edition-of-best-law-firmsAwards & RankingsFirm NewsJones Day named "Law Firm of the Year" in Appellate Practice among 293 rankings in the 2026 edition of Best Law Firms®Thu, 06 Nov 2025 00:00:00 -0600{6E0CFEB9-8DCB-4D5D-A57D-BBB9D58DADC8}https://www.jonesday.com/en/insights/2025/11/fda-proposes-removing-comparative-efficacy-studies-for-biosimilarsAlertFDA Proposes to Remove Comparative Efficacy Studies to Accelerate Biosimilar DevelopmentTue, 04 Nov 2025 00:00:00 -0600{74A21702-2C0C-4BEC-A4FA-E72DA8BFE5B1}https://www.jonesday.com/en/insights/2025/10/california-enacts-sb-53-setting-new-standards-for-frontier-ai-safety-disclosuresAlertCalifornia Enacts SB 53, Setting New Standards for Frontier AI Safety DisclosuresFri, 24 Oct 2025 00:00:00 -0500{D00B2084-3DAF-4ED8-B8AA-661400FFB9C8}https://www.jonesday.com/en/news/2025/10/doj-trial-attorney-alisha-crovetto-returns-to-jones-day-in-washingtonFirm NewsInclusionDOJ trial attorney Alisha Crovetto returns to Jones Day in WashingtonMon, 20 Oct 2025 00:00:00 -0500{D80517DF-A1DE-4764-B997-5BDDA9EB7B91}https://www.jonesday.com/en/insights/2025/10/italy-leads-the-way-in-shaping-national-ai-legislation-within-the-euAlertItaly Leads the Way in Shaping National AI Legislation Within the EUWed, 15 Oct 2025 00:00:00 -0500{7CCF20DB-783C-4279-8DE8-E3BCD7960467}https://www.jonesday.com/en/news/2025/10/the-best-lawyers-in-germany-2026Firm NewsAwards & RankingsThe Best Lawyers in Germany™ 2026 recognizes 55 Jones Day lawyers across 29 practice areasTue, 07 Oct 2025 00:00:00 -0500{76232589-E60D-4C62-8916-B3E275DEEE50}https://www.jonesday.com/en/insights/2025/09/eu-geopolitical-risk-update--key-policy--regulatory-developments-no-122NewslettersEU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 122Tue, 30 Sep 2025 00:00:00 -0500{D9493421-D46D-4266-A4EA-0A13D5E981C1}https://www.jonesday.com/en/insights/2025/09/innovative-insights-legal-updates-in-life-sciences--third-quarter-2025NewslettersInnovative Insights: Legal Updates in Life Sciences | Third Quarter 2025Fri, 26 Sep 2025 00:00:00 -0500{81F1D662-2459-4C78-BA06-C2DA065A6E1F}https://www.jonesday.com/en/news/2025/09/fda-regulatory-lawyer-melissa-mannion-joins-jones-day-in-washingtonFirm NewsInclusionFDA regulatory lawyer Melissa Mannion joins Jones Day in WashingtonTue, 16 Sep 2025 00:00:00 -0500{DD11FC2B-BADE-4FFF-9C7D-513E81EF9CD3}https://www.jonesday.com/en/insights/2025/09/a-return-to-traditional-ma--insights-from-first-merger-challenge-of--trump-administrations-federal-trade-commissionNewslettersA Return to Traditional M&A? Insights from First Merger Challenge of Trump Administration’s Federal Trade CommissionFri, 12 Sep 2025 00:00:00 -0500{E3596757-416B-49B0-A421-503A7A5A63C2}https://www.jonesday.com/en/insights/2025/09/filing-litigation-to-challenge-fda-delays-in-nda-or-bla-reviewNewslettersFiling Litigation to Challenge FDA Delays in NDA or BLA ReviewFri, 12 Sep 2025 00:00:00 -0500{B1851733-1505-424C-ACA2-165A198D9C5F}https://www.jonesday.com/en/insights/2025/09/preparing-for-pharmaceutical-tariffs-what-industry-can-do-to-mitigate-supply-chain-risksNewslettersPreparing for Pharmaceutical Tariffs: What Industry Can Do To Mitigate Supply Chain RisksFri, 12 Sep 2025 00:00:00 -0500{813AF28E-6FD3-412D-A5FD-F75AE435394B}https://www.jonesday.com/en/insights/2025/09/the-future-is-femtech-innovation-and-investment-in-womens-healthNewslettersThe Future is FemTech: Innovation and Investment in Women’s Health Fri, 12 Sep 2025 00:00:00 -0500{B00EA4DB-7B3C-4AB8-B422-9CB204195214}https://www.jonesday.com/en/insights/2025/09/trump-administration-updates-for-the-health-industryNewslettersTrump Administration Updates for the Health IndustryFri, 12 Sep 2025 00:00:00 -0500{84CF1EE2-9F6A-420A-A20B-894F7798E785}https://www.jonesday.com/en/news/2025/09/jones-day-welcomes-former-health-care-fraud-prosecutor-to-health-care--life-sciences-practice-in-san-franciscoFirm NewsInclusionJones Day welcomes former health care fraud prosecutor to Health Care & Life Sciences Practice in San FranciscoTue, 09 Sep 2025 00:00:00 -0500{8FB651C1-A6B5-4309-A88F-38921197BBD7}https://www.jonesday.com/en/news/2025/08/the-best-lawyers-in-america-2026-names-400-jones-day-lawyers-across-71-practice-areasAwards & RankingsFirm NewsThe Best Lawyers in America® 2026 names 400 Jones Day lawyers across 71 practice areasThu, 21 Aug 2025 00:00:00 -0500{044EE54C-52AA-4AF8-BD04-CC9BE5DEBF48}https://www.jonesday.com/en/insights/2025/08/hhs-pilot-program-to-evaluate-340b-drug-pricing-program-rebate-modelsAlertHHS Pilot Program to Evaluate 340B Drug Pricing Program Rebate ModelsFri, 15 Aug 2025 00:00:00 -0500{4B0D74A6-CED1-4D94-A7ED-32036791A878}https://www.jonesday.com/en/insights/2025/08/coming-january-2026-cms-launches-ai-program-to-screen-prior-authorization-requests-for-treatmentsAlertComing January 2026: CMS Launches AI Program to Screen Prior Authorization Requests for TreatmentsWed, 06 Aug 2025 00:00:00 -0500{7CE24DF7-BA30-4D1E-9BCE-166F56A96963}https://www.jonesday.com/en/insights/2025/07/product-regulation-and-metrology-bill-receives-royal-assentAlertProduct Regulation and Metrology Bill Receives Royal AssentWed, 30 Jul 2025 00:00:00 -0500{8B599EA3-A815-42E1-BD5F-42F4A07D6194}https://www.jonesday.com/en/news/2025/07/government-pricing-and-reimbursement-lawyer-stephen-forster-joins-jones-day-as-partner-in-washingtonFirm NewsInclusionGovernment pricing and reimbursement lawyer Stephen Forster joins Jones Day as partner in WashingtonTue, 29 Jul 2025 00:00:00 -0500{D7A94BB1-E500-4A1B-B67B-F27E46A687C4}https://www.jonesday.com/en/insights/2025/07/congress-expands-orphan-drug-exemptions-from-medicare-price-negotiationsAlertCongress Expands Orphan Drug Exemptions From Medicare Price NegotiationsMon, 28 Jul 2025 00:00:00 -0500{5860A5F8-B00E-42FA-9C54-D49B193FBC78}https://www.jonesday.com/en/insights/2025/07/cms-updates-kidney-care-choices-modelAlertCMS Updates Kidney Care Choices ModelFri, 11 Jul 2025 00:00:00 -0500{5E233962-71C0-40BB-BA3D-984CA8C37AF0}https://www.jonesday.com/en/insights/2025/06/uspto-director-denies-ipr-institution-based-on-settled-expectationsCommentaryUSPTO Acting Director Denies IPR Institution Based on "Settled Expectations"Wed, 25 Jun 2025 00:00:00 -0500{F7E0F335-37B6-4C79-8C8E-3FFD4893D2C8}https://www.jonesday.com/en/news/2025/06/former-irs-exempt-organizations-official-mackenzie-mcnaughton-joins-jones-dayFirm NewsInclusionFormer IRS exempt organizations official Mackenzie McNaughton joins Jones DayTue, 17 Jun 2025 00:00:00 -0500{90A1D8C3-AA9A-4AB1-8E55-E0AA1931B6F4}https://www.jonesday.com/en/insights/2025/06/medicares-innovation-center-charts-new-direction-part-3--drugs-devices-and-dataAlertMedicare's Innovation Center Charts New Direction: Part 3 – Drugs, Devices, and DataFri, 13 Jun 2025 00:00:00 -0500{A806D506-13EA-4046-AC16-C3402F872FD8}https://www.jonesday.com/en/insights/2025/06/medicares-innovation-center-charts-new-direction-part-2--digital-health-and-aiAlertMedicare's Innovation Center Charts New Direction: Part 2 – Digital Health and AIThu, 05 Jun 2025 00:00:00 -0500{A9CED3DB-5A18-4EEB-93DA-3F2A2D2E4948}https://www.jonesday.com/en/insights/2025/06/vital-signs-digital-health-law-update--spring-2025NewslettersVital Signs: Digital Health Law Update | Spring 2025Tue, 03 Jun 2025 00:00:00 -0500{7CF8E5AE-15F0-4573-8FC6-7DD2A3B14A3E}https://www.jonesday.com/en/insights/2025/06/california-prosecutors-aggressively-pursue-compliance-with-medical-and-hazardous-waste-disposal-requirementsAlertCalifornia Prosecutors Aggressively Pursue Compliance With Medical and Hazardous Waste Disposal RequirementsMon, 02 Jun 2025 00:00:00 -0500{083AE392-37CE-4994-9AAA-97889DB97CD6}https://www.jonesday.com/en/insights/2025/06/eu-geopolitical-risk-update--key-policy--regulatory-developments-no-121NewslettersEU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 121Mon, 02 Jun 2025 00:00:00 -0500{D8D70F5F-B153-4040-9CFC-344021B75EAD}https://www.jonesday.com/en/insights/2025/06/medicares-innovation-center-charts-new-direction-part-1--providersAlertMedicare's Innovation Center Charts New Direction: Part 1 - ProvidersMon, 02 Jun 2025 00:00:00 -0500{71F1EDF7-BE30-4AA4-8D08-5D1C9D2287A2}https://www.jonesday.com/en/insights/2025/05/doj-criminal-division-announces-priority-enforcement-areas-and-publishes-revised-enforcement-guidanceWhite PaperDOJ Criminal Division Announces Priority Enforcement Areas and Publishes Revised Enforcement GuidanceThu, 22 May 2025 00:00:00 -0500{1D0D72F4-C652-4A63-AEF0-61A538A884BB}https://www.jonesday.com/en/insights/2025/04/judge-blocks-fda-regulation-of-laboratorydeveloped-testsAlertJudge Blocks FDA Regulation of Laboratory-Developed TestsMon, 28 Apr 2025 00:00:00 -0500